Beneath the surface, there are signs of trouble as bullish sentiment reaches a rare extreme. Here are three reasons to be cautious. More
8 Semiconductor Stocks to Sell Now
This week, the overall grades of eight Semiconductor stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
New Guidelines: Doctors to Push Use of Cholesterol Drugs
New heart disease prevention guidelines will have doctors recommending cholesterol drugs to double the Americans than what the current guidelines do. More
7 Biotechnology Stocks to Sell Now
For the current week, the overall ratings of seven Biotechnology stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Looking at the Market into December and Beyond
Charts suggest the market is heading for a solid ending, but be careful heading into the New Year, as a significant indicator is flashing red More
VNDA Stock Nearly Doubles in One Day
Vanda Pharmaceuticals stock nearly doubled in yesterday's trading alone, but a biopharma pick like VNDA is still a risky bet. More
5 Stocks With Prime Earnings Momentum — KNSY MIL ALJ AMED URS
This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader. More
